"In complex cases, the ability to better navigate tortuous anatomy has long been a challenge," said Dr. "The Triumph™ Catheter's nitinol ports and cage bring navigation and control to a new level, and I am excited that Teleflex will enable interventional cardiologists to readily access this important technology." The GuideLiner ® Coast™ Catheter adds a hydrophilic option to Teleflex's market-leading guide extension portfolio-anchored by the flagship GuideLiner ® V3 Catheter-enabling physicians to select the level of deliverability and backup support needed for specific cases. 1 Earlier this year, the GuideLiner ® Coast™ Catheter was first used in a clinical procedure at the UW Medicine Heart Institute in Seattle, Washington. "The Triumph™ Catheter and the GuideLiner ® Coast™ Catheter reflect our focus on providing physicians with new choices and technologies engineered to address unmet clinical needs, personal preference and technique, and the challenges of complex anatomy." "Teleflex is committed to providing more options in the cath lab to help interventionalists address the specific needs of their patients," said Scott Holstine, President and General Manager of Teleflex's Interventional business unit. The GuideLiner ® Coast™ Catheter is currently in a limited market release phase, with full market release anticipated later this year. Both catheters will be on display as part of Teleflex's hands-on workshops during CTO Plus: Complex CTO & Higher Risk PCI, February 23-24 at the New York Marriott Marquis in Times Square. Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. MC-008016 Revised 6/2023.Teleflex is the home of Arrow ®, Deknatel ®, LMA ®, Pilling ®, QuikClot ®, Rusch ®, UroLift ®, and Weck ® – trusted brands united by a common sense of purpose.Īny statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Please contact your local representative. Not all products may be available in all countries. Information in this document is not a substitute for the product Instructions for Use. Teleflex, the Teleflex logo, Coast, and GuideLiner are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S. Please see Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions.ĬAUTION: Federal (USA) law restricts these devices to sale or use by or on the order of a physician. GuideLiner Catheters are contraindicated in vessels less than 2.5mm in diameter and in vessels in the neurovasculature or the venous system. The GuideLiner ® Coast ® Catheter is indicated for CTO in the US and Canada. GuideLiner ® V3 Catheters are indicated for CTO in the US only. GuideLiner ® V3 and GuideLiner ® Coast ® Catheters are intended to be used in conjunction with guide extension catheters to access discrete regions of the coronary and/or peripheral vasculature, to facilitate placement of interventional devices, and to assist in crossing de novo coronary chronic total occlusions (CTO). All values and relative product comparisons are based on bench test data averages (n≥5). Backup support assessed at 2cm extension outside of the guide catheter.Results may not be indicative of clinical performance. GuideLiner ® V3 Catheters required less force in a simulated model. Based upon a review of device experience reports for coronary usage of GuideLiner ® V3 Catheters from launch until November 9, 2022.Bench test results may not necessarily be indicative of clinical performance. Required less force in a simulated model.All comparisons based on bench test results. models and are analyzed with a minimum of 95% confidence as a percentage of the means.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |